December 7, 2016
GeNeuro, Servierhave extend multiple sclerosis study
GeNeuro and Servierhave set up a study they named ANGEL-MS, which is a long-term extension study for patients with multiple sclerosis…
Pharmaceuticals, Biotechnology and Life Sciences
GeNeuro and Servierhave set up a study they named ANGEL-MS, which is a long-term extension study for patients with multiple sclerosis…